Unlocking the secrets of rare cells

MiCareo is pushing beyond the limits of current liquid biopsy technologies by providing high purity isolated live rare cells and automated multiplexed fluorescence imaging. We are building technologies to accelerate the way pharmaceutical companies monitor drug response & screen for drug effectiveness, and giving researchers the tools to find new correlations in biomarker expression using fully quantitative visual subtyping of each cell.